GB2356400A - Drosophila CED-6 homologue and its uses - Google Patents
Drosophila CED-6 homologue and its uses Download PDFInfo
- Publication number
- GB2356400A GB2356400A GB9927347A GB9927347A GB2356400A GB 2356400 A GB2356400 A GB 2356400A GB 9927347 A GB9927347 A GB 9927347A GB 9927347 A GB9927347 A GB 9927347A GB 2356400 A GB2356400 A GB 2356400A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dced
- nucleic acid
- protein
- sequence
- drosophila
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 title claims abstract description 47
- 101000871508 Homo sapiens PTB domain-containing engulfment adapter protein 1 Proteins 0.000 title abstract description 7
- 102100033719 PTB domain-containing engulfment adapter protein 1 Human genes 0.000 title abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 64
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 50
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 45
- 230000001640 apoptogenic effect Effects 0.000 claims abstract description 36
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 31
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 29
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 230000009261 transgenic effect Effects 0.000 claims abstract description 18
- 206010057249 Phagocytosis Diseases 0.000 claims abstract description 17
- 239000013604 expression vector Substances 0.000 claims abstract description 17
- 230000008782 phagocytosis Effects 0.000 claims abstract description 17
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims description 44
- 150000001413 amino acids Chemical class 0.000 claims description 18
- 210000001539 phagocyte Anatomy 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 14
- 108700019146 Transgenes Proteins 0.000 claims description 12
- 239000013598 vector Substances 0.000 claims description 11
- 210000002540 macrophage Anatomy 0.000 claims description 10
- 108020004414 DNA Proteins 0.000 claims description 9
- 230000008827 biological function Effects 0.000 claims description 8
- 239000003623 enhancer Substances 0.000 claims description 7
- 239000003112 inhibitor Substances 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 5
- 230000019491 signal transduction Effects 0.000 claims description 5
- 238000012217 deletion Methods 0.000 claims description 4
- 230000037430 deletion Effects 0.000 claims description 4
- 230000004777 loss-of-function mutation Effects 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 3
- 230000037361 pathway Effects 0.000 claims description 2
- 230000026683 transduction Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 230000014509 gene expression Effects 0.000 description 21
- 238000003556 assay Methods 0.000 description 16
- 210000002257 embryonic structure Anatomy 0.000 description 13
- 101150091502 ced-6 gene Proteins 0.000 description 8
- 230000002018 overexpression Effects 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 7
- 230000006907 apoptotic process Effects 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000242 pagocytic effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 241000255601 Drosophila melanogaster Species 0.000 description 4
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- 238000003782 apoptosis assay Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000005522 programmed cell death Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000014621 translational initiation Effects 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 phosphoamidates Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9927347A GB2356400A (en) | 1999-11-18 | 1999-11-18 | Drosophila CED-6 homologue and its uses |
| PCT/EP2000/011126 WO2001036458A2 (fr) | 1999-11-18 | 2000-11-09 | Homologue ced-6 de la drosophile |
| AU21572/01A AU2157201A (en) | 1999-11-18 | 2000-11-09 | Drosophila ced-6 homologue |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9927347A GB2356400A (en) | 1999-11-18 | 1999-11-18 | Drosophila CED-6 homologue and its uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9927347D0 GB9927347D0 (en) | 2000-01-12 |
| GB2356400A true GB2356400A (en) | 2001-05-23 |
Family
ID=10864778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9927347A Withdrawn GB2356400A (en) | 1999-11-18 | 1999-11-18 | Drosophila CED-6 homologue and its uses |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2157201A (fr) |
| GB (1) | GB2356400A (fr) |
| WO (1) | WO2001036458A2 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489454B1 (en) | 1998-01-23 | 2002-12-03 | Devgen Nv | Engulfment gene and uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037770A1 (fr) * | 1998-01-23 | 1999-07-29 | Cold Spring Harbor Laboratory | Genes de phagocytose et leurs utilisations |
-
1999
- 1999-11-18 GB GB9927347A patent/GB2356400A/en not_active Withdrawn
-
2000
- 2000-11-09 WO PCT/EP2000/011126 patent/WO2001036458A2/fr active Application Filing
- 2000-11-09 AU AU21572/01A patent/AU2157201A/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999037770A1 (fr) * | 1998-01-23 | 1999-07-29 | Cold Spring Harbor Laboratory | Genes de phagocytose et leurs utilisations |
Non-Patent Citations (1)
| Title |
|---|
| EMBL DATABASE, SEQ. ACCESS. NO. AF204777, E SMITS ET AL * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9927347D0 (en) | 2000-01-12 |
| AU2157201A (en) | 2001-05-30 |
| WO2001036458A3 (fr) | 2002-01-10 |
| WO2001036458A2 (fr) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tepass et al. | crumbs encodes an EGF-like protein expressed on apical membranes of Drosophila epithelial cells and required for organization of epithelia | |
| Emerald et al. | Distal antenna and distal antenna related encode nuclear proteins containing pipsqueak motifs involved in antenna development in Drosophila | |
| Andrews et al. | A role for the KP leucine zipper in regulating P element transposition in Drosophila melanogaster. | |
| US20050187378A1 (en) | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides | |
| GB2357768A (en) | GABA B receptors | |
| CA2373628A1 (fr) | Modeles animaux et methodes d'analyse du metabolisme des lipides et criblage d'agents pharmaceutiques et de pesticides modulant le metabolisme des lipides | |
| Fincham et al. | Enamel biomineralization: the assembly and disassembly of the protein extracellular organic matrix | |
| US20040161827A1 (en) | Insect p53 tumor suppressor genes and proteins | |
| Strunk et al. | Role of CtBP in transcriptional repression by the Drosophila giant protein | |
| GB2356400A (en) | Drosophila CED-6 homologue and its uses | |
| WO2000032618A1 (fr) | Acides nucleiques et polypeptides de genes insulinoides de d. melanogaster et leurs utilisations | |
| KR20010071453A (ko) | 식세포의 분석 방법 | |
| US7125976B2 (en) | Method of screening for agents inhibiting chloride intracellular channels | |
| US6579701B1 (en) | Drosophila homologues of genes and proteins implicated in cancer and methods of use | |
| US7060491B1 (en) | Polynucleotides encoding novel BT toxin receptors from lepidopteran insects | |
| JP4510379B2 (ja) | 分裂酵母由来のＩ−ＳｐｏｍＩエンドヌクレアーゼの特徴 | |
| US7135558B1 (en) | Isolated Drosophila proteins essential for survival nucleic acid molecules encoding essential Drosophila proteins, and uses thereof as insecticidal targets | |
| US5942415A (en) | SKAP55 compositions and methods of use therefor | |
| US7037699B2 (en) | Human extracellular signal regulated kinases | |
| US7176285B2 (en) | Histidine phosphatase interacting protein with 120kD | |
| Benassayag et al. | Point mutations within and outside the homeodomain identify sequences required for proboscipedia homeotic function in Drosophila | |
| RU2258531C1 (ru) | Белок, обладающий свойством аспартатной внутримембранной протеазы, способ его получения | |
| Wei | M. Sc., National Yang-Ming Medical College, 1994 | |
| US20020164765A1 (en) | Novel compounds | |
| WO2003044212A2 (fr) | Acides nucleiques et polypeptides de brca2 d'invertebre et procedes d'utilisation associes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1034284 Country of ref document: HK |